Allergy Therapeutics
AGY.L
#6938
Rank
NZ$0.74 B
Marketcap
$15.59
Share price
6.92%
Change (1 day)
23,046.95%
Change (1 year)

Earnings for Allergy Therapeutics (AGY.L)

Earnings in 2024: -NZ$83.13 Million

According to Allergy Therapeutics's latest financial reports the company's current earnings are NZ$69.84 Million. In 2024 the company made an earning of -NZ$83.13 Million, an increase over its 2023 earnings that were of -NZ$88.39 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Allergy Therapeutics from 2002 to 2024

Annual earnings

Year Earnings Change
2024-NZ$83.13 Million-5.94%
2023-NZ$88.39 Million243.12%
2022-NZ$25.76 Million-403.33%
2021NZ$8.49 M-49.05%
2020NZ$16.66 M82.31%
2019NZ$9.14 M-159.83%
2018-NZ$15.29 Million255.37%
2017-NZ$4.3 Million-84.22%
2016-NZ$27.26 Million-1678.94%
2015NZ$1.72 M-44.28%
2014NZ$3.09 M129.45%
2013NZ$1.34 M-19.85%
2012NZ$1.68 M-127%
2011-NZ$6.24 Million2044.94%
2010-NZ$0.3 Million-99.08%
2009-NZ$31.6 Million-53.32%
2008-NZ$67.69 Million-21.76%
2007-NZ$86.51 Million351.81%
2006-NZ$19.15 Million230.51%
2005-NZ$5.8 Million-219.33%
2004NZ$4.85 M-58.79%
2003NZ$11.78 M-196.03%
2002-NZ$12.27 Million